Using Animal Models for Gender-Affirming Hormone Therapy

被引:3
|
作者
Aghi, Krisha [1 ]
Goetz, Teddy G. [2 ]
Pfau, Daniel R. [3 ,4 ,5 ]
Sun, Simon D. [6 ,7 ]
Guthman, Eartha Mae [7 ,8 ]
Roepke, Troy A. [9 ,10 ]
机构
[1] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Div Pediat Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA
[6] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[7] Ctr Appl Transgender Studies, Chicago, IL USA
[8] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA
[9] Rutgers State Univ, Sch Environm & Biol Sci, Dept Anim Sci, New Brunswick, NJ 08901 USA
[10] Rutgers State Univ, 84 Lipman Dr,Bartlett Hall, New Brunswick, NJ 08901 USA
关键词
gender identity; gender-affirming hormone therapy; steroids; estrogens; testosterone; animal models;
D O I
10.1210/jendso/bvad144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have recently proposed experimental design guidelines and areas of study for preclinical rodent models of gender-affirming hormone therapy in neuroscience. These guidelines also apply to any field subject to the influences of gonadal steroid hormones, including metabolism and growth, cancer, and physiology. This perspective briefly describes our suggestions for these fields. Studying the effects of exogenous steroid hormones will have translational benefits for the community. We also discuss the need for equitable practices for cisgender scientists who wish to implement these guidelines and engage with the community. It is necessary that community-informed practices are implemented in preclinical research to maximize the benefit to transgender, nonbinary, and/or gender diverse (TNG) healthcare, which is currently in jeopardy in the United States, Europe, and across the globe.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
    Schutte, Moya H.
    Kleemann, Robert
    Nota, Nienke M.
    Wiepjes, Chantal M.
    Snabel, Jessica M.
    T'Sjoen, Guy
    Thijs, Abel
    den Heijer, Martin
    PLOS ONE, 2022, 17 (03):
  • [32] Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy
    Rothman, Micol S.
    Hamnvik, Ole-Petter R.
    Davidge-Pitts, Caroline
    Safer, Joshua D.
    Ariel, Danit
    Tangpricha, Vin
    Abramowitz, Jessica
    Soe, Kyaw
    Sarvaideo, Jenna
    Kelley, Carly
    Irwig, Michael S.
    Iwamoto, Sean J.
    TRANSGENDER HEALTH, 2024, : 463 - 465
  • [33] Gender Dysphoria and Sexual Euphoria: A Bayesian Perspective on the Influence of Gender-Affirming Hormone Therapy on Sexual Arousal
    Kloebl, Manfred
    Reed, Murray Bruce
    Handschuh, Patricia
    Kaufmann, Ulrike
    Konadu, Melisande Elisabeth
    Ritter, Vera
    Spurny-Dworak, Benjamin
    Kranz, Georg S.
    Lanzenberger, Rupert
    Spies, Marie
    ARCHIVES OF SEXUAL BEHAVIOR, 2024, 53 (05) : 1859 - 1871
  • [34] Serum Hormone Concentrations in Transgender Individuals Receiving Gender-Affirming Hormone Therapy: A Longitudinal Retrospective Cohort Study
    Chantrapanichkul, Panicha
    Stevenson, Mary O.
    Suppakitjanusant, Pichatorn
    Goodman, Michael
    Tangpricha, Vin
    ENDOCRINE PRACTICE, 2021, 27 (01) : 27 - 33
  • [35] The impact of gender-affirming hormone therapy on nutrition-relevant biochemical measures
    Waters, Jennifer
    Linsenmeyer, Whitney
    FRONTIERS IN NUTRITION, 2024, 11
  • [36] The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review
    Allgayer, Roberta M. C. Moreira
    Borba, Gustavo da Silva
    Moraes, Ruy Silveira
    Ramos, Ramon Bossardi
    Spritzer, Poli Mara
    ENDOCRINE PRACTICE, 2023, 29 (06) : 498 - 507
  • [37] Transgender patients and gender-affirming hormone therapy through the mid-life
    Mehta, Jaya M.
    Kanell, Sarah
    Borowicz, Charlie E. A.
    Fisher, Molly Ainsman
    MATURITAS, 2024, 189
  • [38] Expected vs. perceived effects of gender-affirming hormone therapy among transmasculine adolescents
    Taillefer, Valerie
    Kelley, Janie
    Marsolais, Sophie
    Chiniara, Lyne
    Chadi, Nicholas
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2023, 36 (11) : 1072 - 1078
  • [39] Gender-Affirming Hormone Therapy With Estrogen Causing Gallstone Associated Acute Pancreatitis
    Tselovalnikova, Tatiana
    Fatima, Ifrah
    Barthel, Brandon
    AACE CLINICAL CASE REPORTS, 2024, 10 (05): : 210 - 213
  • [40] Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
    Connelly, Paul J.
    Marie Freel, E.
    Perry, Colin
    Ewan, John
    Touyz, Rhian M.
    Currie, Gemma
    Delles, Christian
    HYPERTENSION, 2019, 74 (06) : 1266 - 1274